Acara M, Camiolo S, Rennick B
Drug Metab Dispos. 1977 Jan-Feb;5(1):82-90.
The Sperber technique of infusion into the renal portal circulation in chickens was used to investigate in vivo the renal tubular transport and renal metabolism of trimethylamine (TMA). When 14C-TMA was infused at a rate of 1 x 10(-9) mol/min the transport efficiency (TE), that is, the tubular excretion of the 14C-label relative to excretion of simultaneously infused paminohippuric acid, was 0.70. Progressive addition of unlabeled TMA up to infusion rates of 1 x 10(-5) mol/min produced a progressive fall in the TE of the 14C-label. Identification of the 14C-label excreted in the urine revealed that approximately 85% of the infused 14C-TMA was excreted by the infused kidney as a single metabolite over the entire range of infusions. By use of the techniques of low-voltage electrophoresis, high-voltage electrophoretic mobility-pH profile, and gas chromatography/mass spectrometry, the renal metabolite was found to be identical with standard 14C-trimethylamine oxide (TMAO). At a TMA infusion rate of 1.5 x 10(-6) mol/kg/min reaching the infused kidney, the rate at which TMAO was formed and excreted by the kidney was 0.12 x 10(-6) mol per g of kidney per min. When 14C-TMAO was infused into chickens its TE was 0.11, which was not evidence for active excretory transport. Infused TMA was almost entirely metabolized in vivo to its N-oxide, TMAO, which then entered the urine. The renal tubular excretion of 14C during infusion of 14C-TMA was inhibited by the cationic blocker of transport, quinine, and by the anionic blocker of transport, probenecid.
采用斯珀伯(Sperber)向鸡肾门循环输注的技术,在体内研究三甲胺(TMA)的肾小管转运和肾脏代谢。当以1×10⁻⁹摩尔/分钟的速率输注¹⁴C-TMA时,转运效率(TE),即¹⁴C标记物的肾小管排泄量相对于同时输注的对氨基马尿酸的排泄量,为0.70。逐步添加未标记的TMA直至输注速率达到1×10⁻⁵摩尔/分钟,导致¹⁴C标记物的TE逐渐下降。对尿液中排泄的¹⁴C标记物进行鉴定发现,在整个输注范围内,大约85%的输注¹⁴C-TMA作为单一代谢产物由输注侧肾脏排泄。通过使用低压电泳、高压电泳迁移率-pH图谱以及气相色谱/质谱技术,发现肾脏代谢产物与标准¹⁴C-氧化三甲胺(TMAO)相同。在TMA输注速率为1.5×10⁻⁶摩尔/千克/分钟且到达输注侧肾脏时,肾脏形成并排泄TMAO的速率为每分钟每克肾脏0.12×10⁻⁶摩尔。当将¹⁴C-TMAO输注到鸡体内时,其TE为0.11,这并非主动排泄转运的证据。输注的TMA在体内几乎完全代谢为其N-氧化物TMAO,然后进入尿液。在输注¹⁴C-TMA期间,¹⁴C的肾小管排泄受到转运阳离子阻滞剂奎宁和转运阴离子阻滞剂丙磺舒的抑制。